Surf Bio

📍 Palo Alto, United States👥 4 employees💰 Last funded Apr 2022
Biotechnology Research🌐 surf.bio
Website LinkedIn
Surf Bio is a preclinical biopharmaceutical company leveraging a novel biotechnology platform to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC to commercialize a breakthrough drug stabilization technology developed in the Appel Lab. Commercially, the technology is designed to enable reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations across a range of therapeutic areas. For more information about Surf Bio, visit www.surf.bio.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Surf Bio?
Surf Bio has 1 investors on record on gritt.io.
When did Surf Bio last raise funding?
The most recent investment in Surf Bio recorded on gritt.io was in April 2022.
What industry is Surf Bio in?
Surf Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Surf Bio based?
Surf Bio is headquartered in Palo Alto, United States.